Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-488-3 | CAS number: 1471311-93-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 35.26 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 50
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1 763.15 mg/m³
- Explanation for the modification of the dose descriptor starting point:
The oral rat NOAEL was converted into the inhalative human NOAEC corrected for differences
between the 8-hour standard inhalation volume of rats versus humans, and for differences between the 8-hour inhalation volume of workers in rest versus workers in light activity, by multiplying with the corresponding factors (x 1/0.38 m³/kg/d x 6.7 m³/10 m³). The resulting corrected starting point for inhalation DNEL derivation for workers is equal to 1763.15 mg/m³.see discussion
- AF for dose response relationship:
- 1
- Justification:
- no additional issues, default
- AF for differences in duration of exposure:
- 2
- Justification:
- sub chronic to chronic, default
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- allometric scaling already considered in starting point conversion, see above
- AF for other interspecies differences:
- 2.5
- Justification:
- default
- AF for intraspecies differences:
- 5
- Justification:
- worker, default
- AF for the quality of the whole database:
- 1
- Justification:
- no additional issues, default
- AF for remaining uncertainties:
- 2
- Justification:
- oral to inhalation conversion, default
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 10 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
There is no data available indicating that dermal uptake is considerably lower than oral uptake.
The oral systemic long-term NOAEL was therefore considered appropriate for derivation of a dermal systemic long-term DNEL without further correction. Hence, the NOAEL oral is transferred to a NOAEL dermal without correction.
- AF for dose response relationship:
- 1
- Justification:
- no additional issues, default
- AF for differences in duration of exposure:
- 2
- Justification:
- sub chronic to chronic, default
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- rat allometric scaling, default
- AF for other interspecies differences:
- 2.5
- Justification:
- remainig differences, default
- AF for intraspecies differences:
- 5
- Justification:
- worker, default
- AF for the quality of the whole database:
- 1
- Justification:
- no quality issue, default
- AF for remaining uncertainties:
- 1
- Justification:
- no further uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
Worker:
Based on the available data “Reaction product of “Maleic anhydride, 2-Ethylhexylamine and Triethanolamine”, has to be considered as irritating to the skin (R38 according to Directive 67/548/EEC annex VI; Cat. 2 according to EC/1271/2008), posing the risk of serious eye damage (R41/Cat. 1) and potentially skin sensitizing (R43; Cat. 1B), respectively.
For the sensitization and skin or eye irritation potential, only a qualitative assessment can be conducted. Though such reactions of the skin are generally regarded as threshold effect, deriving a threshold and setting a DNEL is very difficult in practice especially based on common test systems because no dose-response data of the tested substance can be derived from test available here and therefore no quantitative determination of a DNEL for e.g. skin sensitization is possible.
The primary routes of anticipated industrial and professional exposure are via inhalation and skin contact. In industrial settings, ingestion is not an anticipated route of exposure, but has to be considered for the general population (see below).
Dermal short-term and long-term exposure – local effects:
As no dose response information for these local effects exists, the use of protective gloves and appropriate eye protection is mandatory for worker whenever a potential for relevant ocular or dermal exposure exists. RMM as well as information on the hazard of the substance are communicated via the safety data sheet. Further the workers are trained in using personal protective equipment which ensure the safe handling of the substance. Therefore the risk concerning skin sensitization, skin irritiation and eye damage is adequately communicated and RMMs are in place to assure the risk adequately controlled. (Further detailed information are given within the CSR)
Inhalation long-term exposure – systemic:
The NOAEL from an oral OECD Guideline 408 study (90d Test) (BASF SE, 2019) was identified as the most sensitive and appropriate starting point for DNEL derivation for long-term exposure following inhalation. The NOAEL for general, systemic toxicity of the test substance was 1000 mg/kg bw/d for rats within this subchronic study.
This point of departure was modified to get the corrected starting point for DNEL derivation. As a first step, route-to-route extrapolation was performed as recommended in the "Guidance on information requirements and chemical safety assessment, Chapter R.8, p. 26 f.:
The oral rat NOAEL was converted into the inhalative human NOAEC corrected for differences between the 8-hour standard inhalation volume of rats versus humans, and for differences between the 8-hour inhalation volume of workers in rest versus workers in light activity, by multiplying with the corresponding factors (x 1/0.38 m³/kg/d x 6.7 m³/10 m³). The resulting corrected starting point for inhalation DNEL derivation for workers is equal to 1763.15 mg/m³.
For DNEL derivation, the following assessment factors (AF) according to ECHA default assumption are choosen:
- Interspecies factor: 1 (allometric scaling already considered in starting point conversion, see above)
- remaining Interspecies differences: 2.5 (default)
- Intraspecies factor: 5 (worker, default)
- Exposure duration: 2 (sub chronic to chronic, default)
- Dose-response: 1 (no additional issues, default)
- Oral to Inhalation additional default factor: 2
Total AF = 2.5 x 5 x 2 x 1 x 2 = 50
Based on this calculation the resulting DNEL inhalative, systemic, worker is 35.26 mg/m³.
Dermal long-term exposure – systemic effects:
The NOAEL from an oral OECD Guideline 408 study (90d Test) (BASF SE, 2019) was identified as the most sensitive and appropriate starting point for DNEL derivation for long-term exposure following inhalation. The NOAEL for general, systemic toxicity of the test substance was 1000 mg/kg bw/d for rats within this subchronic study.
There is no data available indicating that dermal uptake is considerably lower than oral uptake. The oral systemic long-term NOAEL was therefore considered appropriate for derivation of a dermal systemic long-term DNEL without further correction. Hence, the NOAEL oral is transferred to a NOAEL dermal without correction.
For DNEL derivation, the following assessment factors (AF) according to ECHA default assumption are choosen:
- Interspecies factor: 4 (rat allometic scaling, default)
- remaining Interspecies differences: 2.5 (default)
- Intraspecies factor: 5 (worker, default)
- Exposure duration: 2 (sub chronic to chronic, default)
- Dose-response: 1 (no additional issues, default)
Total AF = 4 x 2.5 x 5 x 2 x 1 = 100
Based on this calculation the resulting DNEL dermal, systemic, worker is 10 mg/kg bw/day.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 8.7 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 869.56 mg/m³
- Explanation for the modification of the dose descriptor starting point:
This point of departure was modified to get the correct starting point for DNEL derivation.
As a first step, route-to-route extrapolation was performed as recommended in the "Guidance on information requirements and chemical safety assessment, Chapter R.8, p. 26 f.:
The oral rat NOAEL was converted into the inhalative human NOAEC corrected for differences between the 24-hour standard inhalation volume of rats versus humans by multiplying with the corresponding factor (x 1/1.15 m³/kg/d). The resulting corrected starting point for inhalation DNEL derivation for the general population is equal to 869.56 mg/m³.
- AF for dose response relationship:
- 1
- Justification:
- no additional issue, default
- AF for differences in duration of exposure:
- 2
- Justification:
- sub chronic to chronic, default
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- allometric scaling already considered in starting point conversion, see above
- AF for other interspecies differences:
- 2.5
- Justification:
- remaining interspecies differences, default
- AF for intraspecies differences:
- 10
- Justification:
- consumer, default
- AF for the quality of the whole database:
- 1
- Justification:
- no additional issue, default
- AF for remaining uncertainties:
- 2
- Justification:
- oral to inhalation conversion
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
There is no data available indicating that dermal uptake is considerably lower than oral uptake. The oral systemic long-term NOAEL was therefore considered appropriate for derivation of a dermal systemic long-term DNEL without further correction.
Hence, the NOAEL oral is transferred to a NOAEL dermal without correction.
- AF for dose response relationship:
- 1
- Justification:
- no additional issues, default
- AF for differences in duration of exposure:
- 2
- Justification:
- sub chronic to chronic, default
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- rat, default
- AF for other interspecies differences:
- 2.5
- Justification:
- remaining differences, default
- AF for intraspecies differences:
- 10
- Justification:
- consumer, default
- AF for the quality of the whole database:
- 1
- Justification:
- no additional issues, default
- AF for remaining uncertainties:
- 1
- Justification:
- no additional issues, default
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- The NOAEL of 1000 mg/kg bw/day was considered appropriate as point of departure for DNEL derivation. No additional reduction were used.
- AF for dose response relationship:
- 1
- Justification:
- no additional issues, default
- AF for differences in duration of exposure:
- 2
- Justification:
- sub chronic to chronic, default
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- rat, default
- AF for other interspecies differences:
- 2.5
- Justification:
- remaining uncertainties, default
- AF for intraspecies differences:
- 10
- Justification:
- consumer, default
- AF for the quality of the whole database:
- 1
- Justification:
- no additional issues, default
- AF for remaining uncertainties:
- 1
- Justification:
- no additional issues, default
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
Consumer
Based on the available data “Reaction product of Maleic anhydride, 2-Ethylhexylamine and Triethanolamine”, has to be considered as irritating to the skin (R38 according to Directive 67/548/EEC annex VI; Cat. 2 according to EC/1271/2008), posing the risk of serious eye damage (R41/Cat. 1) and potentially skin sensitizing (R43; Cat. 1B), respectively.
For the sensitization and skin or eye irritation potential, only a qualitative assessment can be conducted. Though such reactions of the skin are generally regarded as threshold effect, deriving a threshold and setting a DNEL is very difficult in practice especially based on common test systems because no dose-response data of the tested substance can be derived from test available here and therefore no quantitative determination of a DNEL for e.g. skin sensitization is possible.
For the general population, all three possible routes of exposure (oral, dermal, inhalation) have to be taken into account.
Dermal short-term and long-term exposure – local effects:
As no dose response information for these local effects exists, the risk assessment for consumer is performed, if consumer uses are available on a qualitative base. (For detailed information see CSR)
Inhalation long-term exposure – systemic:
The NOAEL from an oral OECD Guideline 408 study (90d Test) (BASF SE, 2019) was identified as the most sensitive and appropriate starting point for DNEL derivation for long-term exposure following inhalation. The NOAEL for general, systemic toxicity of the test substance was 1000 mg/kg bw/d for rats within this subchronic study.
This point of departure was modified to get the correct starting point for DNEL derivation. As a first step, route-to-route extrapolation was performed as recommended in the "Guidance on information requirements and chemical safety assessment, Chapter R.8, p. 26 f.:
The oral rat NOAEL was converted into the inhalative human NOAEC corrected for differences between the 24-hour standard inhalation volume of rats versus humans by multiplying with the corresponding factor (x 1/1.15 m³/kg/d). The resulting corrected starting point for inhalation DNEL derivation for the general population is equal to 869.56 mg/m³.
For DNEL derivation, the following assessment factors (AF) according to ECHA default assumption are choosen:
- Interspecies factor: 1 (allometric scaling already considered in starting point conversion, see above)
- remaining Interspecies differences: 2.5
- Intraspecies factor: 10 (consumer, default)
- Exposure duration: 2 (sub chronic to chronic, default)
- Dose-response: 1 (no additional issues, default)
- Oral to Inhalation additional default factor: 2
Total AF = 2.5 x 5 x 2 x 1 x 2 = 100
Based on this calculation the resulting DNEL inhalation, systemic, consumer is 8.7 mg/m³.
Dermal long-term exposure – systemic effects:
The NOAEL from an oral OECD Guideline 408 study (90d Test) (BASF SE, 2019) was identified as the most sensitive and appropriate starting point for DNEL derivation for long-term exposure following inhalation. The NOAEL for general, systemic toxicity of the test substance was 1000 mg/kg bw/d for rats within this subchronic study.
There is no data available indicating that dermal uptake is considerably lower than oral uptake. The oral systemic long-term NOAEL was therefore considered appropriate for derivation of a dermal systemic long-term DNEL without further correction. Hence, the NOAEL oral is transferred to a NOAEL dermal without correction.
For DNEL derivation, the following assessment factors (AF) according to ECHA default assumption are choosen:
- Interspecies factor: 4 (rat, default)
- remaining Interspecies differences: 2.5 (default)
- Intraspecies factor: 10 (consumer, default)
- Exposure duration: 2 (sub chronic to chronic, default)
- Dose-response: 1 (no additional issues, default)
Total AF = 4 x 2.5 x 10 x 2 x 1 = 200
Based on this calculation the resulting DNEL dermal, systemic, consumer is 5 mg/kg bw/day.
Oral long-term exposure – systemic effects:
The NOAEL from an oral OECD Guideline 408 study (90d Test) (BASF SE, 2019) was identified as the most sensitive and appropriate starting point for DNEL derivation for long-term exposure following inhalation. The NOAEL for general, systemic toxicity of the test substance was 1000 mg/kg bw/d for rats within this subchronic study.
The NOAEL of 1000 mg/kg bw/day was considered appropriate as point of departure for DNEL derivation. No additional reduction were used.
For DNEL derivation, the following assessment factors (AF) according to ECHA default assumption are choosen:
- Interspecies factor: 4 (rat, default)
- remaining Interspecies differences: 2.5 (default)
- Intraspecies factor: 10 (consumer, default)
- Exposure duration: 2 (sub chronic to chronic, default)
- Dose-response: 1 (no additional issues, default)
Total AF = 4 x 2.5 x 10 x 2 x 1 = 200
Based on this calculation the resulting DNEL oral, systemic, consumer is 5 mg/kg bw/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)